Author

Yajing Xu

Observed name: Ya-jing Xu

Institutions: Central South University, Xiangya Hospital Central South University

Observed institutions: Central South University, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Wenzhou Central Hospital, First Affiliated Hospital of Soochow University, Xiangya Hospital Central South University

ORCID: 0000-0003-2847-2547

Observed ORCID: 0000-0003-2847-2547

OpenAlex ID: A5114626865

Efficacy and Safety of Brl-101, CRISPR-Cas9-Mediated Gene Editing of the BCL11A Enhancer in Transfusion-Dependent β-Thalassemia

2023 · Biao Zheng, Rongrong Liu, et al. · Blood · 14

Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer

2021 · Xiaowei Huang, Chan Chen, et al. · Bioengineered · 11

NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World Study

2025 · Xiaolin Yuan, Lihong Ni, et al. · Transplantation and Cellular Therapy · 6

Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients

2022 · Tingting Cheng, Yan Chen, et al. · Frontiers in Oncology · 5

Haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood in hematologic malignancy patients: A report of 80 cases

2022 · Cong Zeng, Yan Chen, et al. · Frontiers in Immunology · 4

Cladribine and medium-dose cytarabine intensified busulfan plus cyclophosphamide conditioning regimen for adults high-risk B-cell acute lymphoblastic leukemia

2025 · Tingting Cheng, Jie Peng, et al. · Annals of Hematology · 3

Safety and efficacy of lisaftoclax, a novel BCL-2 inhibitor, in combination with azacitidine in patients with treatment-naïve or relapsed or refractory acute myeloid leukemia.

2024 · Huafeng Wang, Xudong Wei, et al. · Journal of Clinical Oncology · 3

IFN-γ induces acute graft-versus-host disease by promoting HMGB1-mediated nuclear-to-cytoplasm translocation and autophagic degradation of p53

2024 · Shiyu Wang, Tingting Cheng, et al. · Clinical Science · 2

Identification of immune subtypes associated with CD8+ T cell-related genes providing new treatment strategies of esophageal carcinoma

2025 · Youyi Wu, Chen Lin, et al. · Frontiers in Immunology · 1

The Aberrantly Expressed Nuclear Factor (Erythroid-derived 2)-Like 2 Participates in aGVHD by Modulating the Activation and Differentiation of CD4+ T Lymphocytes

2025 · Xu Chen, Yue Zhang, et al. · Transplantation · 1

A Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients with Relapsed/Refractory Acute Myeloid Leukemia

2023 · Junyuan Qi, Lin Song, et al. · Blood · 1

Caregivers’ proxy assessments of health-related quality of life in patients with hematologic malignancies

2026 · Wei Qin, Fenfang Tong, et al. · Supportive Care in Cancer

Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China

2026 · Wei Qin, Ya Chen, et al. · BMJ Open

Works count: 13

Citation count: 51

H-index: 4

I10-index: 2